Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Acta Geneticae Medicae Et Gemellologiae
|
January 1, 1979
Variability of plantar zygodactylous triradii in monozygotic and dizygotic twins
G Aue-Hauser, H Lebioda, H Szczotka, et al.
Annals of Surgical Oncology
|
November 27, 1998
Telomerase activity in skeletal sarcomas
G Aue, B Muralidhar, H S Schwartz, et al.
Leukemia
|
March 15, 2013
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies
M Roschewski, M Farooqui, G Aue, et al.
Der Internist
|
November 4, 2008
[A 62 year old woman with spontaneous onset of distinct walking disorder and pancytopenia]
T Austein, S Badge, H Kerstan, et al.
Cancer Genetics and Cytogenetics
|
August 5, 1998
Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation
G Aue, L K Hedges, H S Schwartz, et al.
Cancer Genetics and Cytogenetics
|
September 2, 1998
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages
M G Butler, J Tilburt, A DeVries, et al.
Bone Marrow Transplantation
|
January 10, 2017
Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation
E McDuffee, G Aue, L Cook, et al.
The Journal of Allergy and Clinical Immunology
|
July 17, 2020
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)
Bin Lin, Roberta Berard, Abdulrahman Al Rasheed, et al.
Frontiers in Immunology
|
April 9, 2021
Case Report: Novel SAVI-Causing Variants in <i>STING1</i> Expand the Clinical Disease Spectrum and Suggest a Refined Model of STING Activation
Bin Lin, Sofia Torreggiani, Dana Kahle, et al.
Leukemia
|
April 27, 2013
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy
S E M Herman, X Sun, E M McAuley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Acta Geneticae Medicae Et Gemellologiae
|
January 1, 1979
Variability of plantar zygodactylous triradii in monozygotic and dizygotic twins
G Aue-Hauser, H Lebioda, H Szczotka, et al.
Annals of Surgical Oncology
|
November 27, 1998
Telomerase activity in skeletal sarcomas
G Aue, B Muralidhar, H S Schwartz, et al.
Leukemia
|
March 15, 2013
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies
M Roschewski, M Farooqui, G Aue, et al.
Der Internist
|
November 4, 2008
[A 62 year old woman with spontaneous onset of distinct walking disorder and pancytopenia]
T Austein, S Badge, H Kerstan, et al.
Cancer Genetics and Cytogenetics
|
August 5, 1998
Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation
G Aue, L K Hedges, H S Schwartz, et al.
Cancer Genetics and Cytogenetics
|
September 2, 1998
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages
M G Butler, J Tilburt, A DeVries, et al.
Bone Marrow Transplantation
|
January 10, 2017
Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation
E McDuffee, G Aue, L Cook, et al.
The Journal of Allergy and Clinical Immunology
|
July 17, 2020
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)
Bin Lin, Roberta Berard, Abdulrahman Al Rasheed, et al.
Frontiers in Immunology
|
April 9, 2021
Case Report: Novel SAVI-Causing Variants in <i>STING1</i> Expand the Clinical Disease Spectrum and Suggest a Refined Model of STING Activation
Bin Lin, Sofia Torreggiani, Dana Kahle, et al.
Leukemia
|
April 27, 2013
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy
S E M Herman, X Sun, E M McAuley, et al.
Page
of 3